Kelly CRISPR & Gene Editing Tech ETF Analysis

Kelly CRISPR & Gene Editing Tech Profile

About Kelly CRISPR & Gene Editing Tech

The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.

Kelly CRISPR & Gene Editing Tech Sectors